Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00110435
Status:
COMPLETED
Last Update Posted:
2022-02-16
First Post:
2005-05-09
Brief Title:
A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia MK-0653A-077
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
A Multicenter Randomized Double-blind Parallel Group 6-Week Study to Evaluate the Efficacy and Safety of EzetimibeSimvastatin Combination Tablet Versus Atorvastatin in Patients With Type 2 Diabetes Mellitus T2DM and Hypercholesterolemia
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this 10-week study is to compare the reduction in cholesterol following treatment with two different marketed drugs in patients with type 2 diabetes mellitus and hypercholesterolemia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005_022 | None | None | None |
| MK0653A-077 | None | None | None |